Lung Cancer Wherein Durvalumab Induced Both Anti-CRMP-5 Antibody-related Paraneoplastic Neurological Syndromes and Neurological Adverse Events.
| Autor: | Tomokazu Seki, Kousuke Baba, Tomohiro Hayashi, Risako Furuta, Hiroaki Hirosawa, Taichi Mitsui, Hiroki Maesaka, Syuhei Takasawa, Toshiro Miwa, Keiko Tanaka, Yuji Nakatsuji |
|---|---|
| Zdroj: | Internal Medicine; 2024, Vol. 54 Issue 7, p1009-1014, 6p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|